Switzerland· 60025002

Enbrel MyClic

A etanercept product containing etanerceptum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC L04AB01

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedEnbrel MyClicATCL04AB01REGISTER NO.60025002PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Etanercept is registered in 14 of 19 countries.

Countries holding a registration under ATC L04AB01 (etanercept), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Etanercept · ATC L04AB01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of etanercept costs, country by country.

Normalised to the WHO defined daily dose (7 mg), the median price runs from $0.35 in Finland to $35.22 in Switzerland — a ×100 gap.

  • Switzerland: $35.22 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Etanercept · price per daily dose (7 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$35.22
  • FI Finland$0.35
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
etanerceptum
Manufacturer
—
Country
Switzerland (CH)
ATC code
L04AB01
ATC class
Etanercept
Defined daily dose
7 mg, P
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680600250024
    2 Fertpen 1 ml
    CHF 455.15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

429 interactions on record for etanercept.

Graded by severity as the source publishes them — 287 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Etanercept · interactions on record

429 records

  • 287 severe
  • 135 moderate
  • 7 minor

Most severe, free to view

  • PrednisoloneA07EA01severe
  • HydrocortisoneA07EA02severe
  • PrednisoneA07EA03severe
  • BetamethasoneA07EA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Etanercept in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etanercept products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Enbrel, Enbrel For Paediatric Use
  • Liechtenstein · Enbrel, Enbrel For Paediatric Use
  • Norway · Enbrel, Enbrel For Paediatric Use

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a68c9efa-5d3a-4c9b-bb49-e0a1fecd74c3
GET /v1/drugs/a68c9efa-5d3a-4c9b-bb49-e0a1fecd74c3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "etanerceptum 50 mg",
  "valid_from": "2017-02-01",
  "limitations": "[{\"description\":\"Die Behandlung mit ENBREL bedarf der Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes.<br>\\n<br>\\n<b>Rheumatoide Arthritis, aktive juvenile chronische Arthritis mit polyartikulärem Verlauf und Psoriasis Arthritis</b><br>\\nBehandlung der aktiven rheumatoiden Arthritis, der aktiven juvenilen chronischen Arthritis mit polyartikulärem Verlauf und Psoriasis Arthritis, wenn die vorausgegangene antirheumatische Standardtherapie mit krankheitsmodifizierenden Antirheumatika (DMARDs) unzulänglich war.<br>\\n<br>\\n<b>Morbus Bechterew (Ankylosierende Spondylitis)</b><br>\\nBehandlung des Morbus Bechterew, wenn die vorausgegangene konventionelle Therapie unzulänglich war.<br>\\n<br>\\n<b>Schwere Plaque Psoriasis</b><br>\\nBehandlung erwachsener Patienten mit schwerer Plaque-Psoriasis, bei denen eine Phototherapie oder eine der folgenden konventionellen systemischen Therapien (Ciclosporin, Methotrexat, Acitretin) keinen therapeutischen Erfolg gezeigt haben. Falls nach 12 Wochen kein therapeutischer Erfolg eingetreten ist, ist die Behandlung abzubrechen. Standarddosierung pro Behandlungszyklus: 1 x 50 mg pro Woche oder 2 x 25 mg pro Woche während 24 Wochen. In Ausnahmefällen kann die Dosierung während 12 Wochen auf maximal 2 x 50 mg pro Woche erhöht werden. Die Verschreibung kann nur durch Fachärzte der Dermatologie oder dermatologische Universitätskliniken/Polikliniken erfolgen.<br>\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2021-08-01\",\"validTo\":null}]",
  "galenic_form": "Inj Lös 50 mg/ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2010-10-01",
  "self_retention_pct": 10
}

See everything about etanercept.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.